Orphan Drug Pricing Is Different. Here Is Why Discretionary Pricing Matters
Manufacturer pricing choices on orphan drugs are not fixed. They shift, and most hospitals are not tracking those changes closely enough.
This article covers how discretionary pricing works, why recent 340B pricing changes have made this issue more relevant than ever, and what a solid tracking process actually looks like inside a busy pharmacy department.
You will learn how to identify affected drugs, request pricing directly from manufacturers, and keep watching for changes long after the first ask goes out.
Read the full article here and build a process that keeps up with manufacturer decisions.
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek